Testing goat milk protein tolerance in patients with eosinophilic esophagitis triggered by cow milk
Official title: Tolerability of Goat Milk Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein Trigger
Run by Shaare Zedek Medical Center · NCT05180578 · Data updated 2026-11-12
This study is testing if people with eosinophilic esophagitis who can't tolerate cow milk can safely drink goat milk without having a bad reaction.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 18 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Shaare Zedek Medical Center Academic / other |
| Locations | 1 site (Jerusalem) |
| Status | Recruiting |
| Started | November 12, 2020 |
| Main results expected | October 2025 |
| Study ends | October 2025 |
| Registry record updated | May 22, 2025 |
| Trial ID | NCT05180578 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 17.5 years or younger diagnosed with eosinophilic esophagitis and confirmed to have cow's milk as a trigger.
✕Probably not a fit
Patients with clinical IgE-mediated milk allergy or those who test positive for cow milk allergens will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the tolerability of goat milk protein in patients diagnosed with eosinophilic esophagitis (EoE) who have identified cow milk as a dietary trigger. Participants will undergo a thorough screening process, including endoscopy and allergy testing, to ensure they are suitable candidates for the trial. Following a strict milk-free diet, patients will be introduced to a goat milk diet to assess their tolerance and any potential allergic reactions. The study will monitor symptoms and histological changes through follow-up endoscopies.
Why it matters
Potential benefit: If successful, this study could provide an alternative dietary option for patients with eosinophilic esophagitis who are sensitive to cow milk.
How similar studies have gone: While there is limited data on the cross-reactivity of milk from different species, similar dietary interventions have shown promise in managing eosinophilic esophagitis.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients diagnosed with EoE age ≤ 17.5 years at inclusion who were confirmed to have cow's milk as a trigger by demonstrating improvement during elimination and histologic relapse following reintroduction. * Verified histologic remission on milk-free diet on endoscopy prior to intervention * Proton-pump inhibitors may be used if treatment is maintained at the same dose from the screening endoscopy throughout the trial period, and was used at the time that milk was demonstrated to be the triggering food. * Ability to consent to enrollment in the trial - legal guardians with joint consent for patients \>10 years. Exclusion Criteria: * Patients with clinical IgE-mediated milk allergy. * Provisional exclusion: patients without a known IgE-mediated allergic reaction to milk who have a positive RAST (as per local reference range) or positive skin-prick test for cow milk or goat milk must be assessed by a certified allergist/immunologist and cleared for the trial by a supervised goat milk challenge. * Use of inhaled corticosteroids for more than 5 days per month during the trial period.
Where it's running
-
Shaare Zedek
Jerusalem, Israel Recruiting
Study contacts
- Study coordinator: Oren Ledder, Dr.
- Email: orenl@szmc.org.il
- Phone: +972-2-6666743
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Upadacitinib for Eosinophilic Esophagitis in adults not responding to standard therapy
This study tests whether upadacitinib, taken with topical corticosteroids, can reduce disease activity in adults with eosinophilic esophagitis who still have symptoms.
-
A registry for adults with esophageal movement and reflux problems.
This project will collect esophageal function tests (manometry, pH-impedance, FLIP) and clinical data from adults with reflux or swallowing symptoms to see if combining these results helps guide diagnosis and long-term care.
-
Using a mucosal impedance device to help diagnose chronic esophageal problems
This test tries a mucosal impedance device during upper endoscopy to see if it helps diagnose people with chronic reflux (GERD) or eosinophilic esophagitis.
-
Esophageal string test to screen for eosinophilic esophagitis in adults of African descent with swallowing problems
This study will test whether a 1-hour esophageal string test can detect eosinophilic esophagitis in adults born in Africa (or with African parents) who have trouble swallowing.
-
Improving management of eosinophilic esophagitis in children and adolescents
This study is trying to find better ways to manage eosinophilic esophagitis in kids and teens by using simple tests to avoid invasive procedures and improve their quality of life.
-
How common FIRE is and what it looks like in children with eosinophilic esophagitis
This project will see how often and in what ways Food Induced Immediate Response of the Esophagus (FIRE) occurs in children aged 6–17 who have eosinophilic esophagitis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.